{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:17:25Z","timestamp":1789773445955,"version":"4.0.1"},"reference-count":64,"publisher":"The Endocrine Society","issue":"7","license":[{"start":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T00:00:00Z","timestamp":1736208000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100007028","name":"Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Diabetes in pregnancy increases risk for complications for the pregnant patient and neonate. Tight glycemic control to maintain glucose levels as close to nondiabetic ranges as possible can lower risk for these complications. Achieving strict glycemic targets can be challenging, and technologies including continuous glucose monitors (CGMs) and hybrid closed-loop (HCL) insulin pumps have the potential to improve diabetes control and pregnancy outcomes. The aim of this review is to present and appraise the current data about use of these technologies in pregnancy. In pregnancies with type 1 diabetes (T1D), CGM can improve glycemic control and reduce risk for neonatal complications. International consensus guidelines recommend more than 70% time in pregnancy target range (TIR) of 63 to 140\u2005mg\/dL (3.5-7.8\u2005mmol\/L), and there are data to suggest higher TIR in pregnancies with T1D can reduce risk for neonatal complications including fetal overgrowth and pregnancy complications like preeclampsia. Recent randomized controlled trials have demonstrated improved glycemic outcomes with use of HCL insulin pumps in pregnancy with T1D, though the results vary depending on the system used and available glycemic targets. In pregnancies with type 2 diabetes (T2D) and gestational diabetes mellitus (GDM), retrospective data suggest CGM can improve glycemia but there are limited data about outcomes or optimal CGM targets. Studies have reported glycemic measures for pregnancies without diabetes, which may serve as a guide for further outcomes studies of T2D and GDM. Access to diabetes technology and the necessary health care systems to support use of these devices may be barriers that contribute to health care disparities.<\/jats:p>","DOI":"10.1210\/clinem\/dgae914","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T04:17:45Z","timestamp":1735877865000},"page":"e2317-e2326","source":"Crossref","is-referenced-by-count":6,"title":["Approach to the Patient Using Diabetes Technology in Pregnancy"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7404-0388","authenticated-orcid":false,"given":"Laura T","family":"Dickens","sequence":"first","affiliation":[{"name":"Section of Adult and Pediatric Endocrinology, Diabetes, and Metabolism, University of Chicago , Chicago, IL 60637 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maritza G","family":"Gonzalez","sequence":"additional","affiliation":[{"name":"Section of Maternal Fetal Medicine, Obstetrics and Gynecology, University of Chicago , Chicago, IL 60637 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2025,1,7]]},"reference":[{"key":"2025062422033822800_dgae914-B1"},{"issue":"6","key":"2025062422033822800_dgae914-B2","doi-asserted-by":"crossref","first-page":"e228","DOI":"10.1097\/AOG.0000000000002960","article-title":"ACOG practice bulletin No. 201: pregestational diabetes mellitus","volume":"132","author":"American College of Obstetricians and Gynecologists\u2019 Committee on Practice Bulletins\u2014Obstetrics","year":"2018","journal-title":"Obstet Gynecol"},{"issue":"1","key":"2025062422033822800_dgae914-B3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.15585\/mmwr.mm7201a4","article-title":"QuickStats: percentage of mothers with gestational diabetes, * by maternal age\u2014national vital statistics system, United States, 2016 and 2021","volume":"72","year":"2023","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"Supplement_1","key":"2025062422033822800_dgae914-B4","doi-asserted-by":"crossref","first-page":"S282","DOI":"10.2337\/dc24-S015","article-title":"15. Management of diabetes in pregnancy: standards of care in diabetes-2024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"issue":"19","key":"2025062422033822800_dgae914-B5","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"HAPO Study Cooperative Research Group","year":"2008","journal-title":"N Engl J Med"},{"issue":"8","key":"2025062422033822800_dgae914-B6","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"suppl_1","key":"2025062422033822800_dgae914-B7","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.2337\/diacare.27.2007.S76","article-title":"Preconception care of women with diabetes","volume":"27","author":"American Diabetes Association","year":"2004","journal-title":"Diabetes Care"},{"issue":"5","key":"2025062422033822800_dgae914-B8","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1464-5491.2012.03604.x","article-title":"Hypoglycaemia during pregnancy in women with type 1 diabetes","volume":"29","author":"Ringholm","year":"2012","journal-title":"Diabet Med"},{"issue":"3","key":"2025062422033822800_dgae914-B9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00125-009-1633-z","article-title":"Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction","volume":"53","author":"Garc\u00eda-Patterson","year":"2010","journal-title":"Diabetologia"},{"issue":"6","key":"2025062422033822800_dgae914-B10","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1210\/jc.2018-00094","article-title":"Parity increases insulin requirements in pregnant women with type 1 diabetes","volume":"103","author":"Skajaa","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2025062422033822800_dgae914-B11","doi-asserted-by":"crossref","first-page":"e3771","DOI":"10.1002\/dmrr.3771","article-title":"Insulin requirements during pregnancy in women with type 1 diabetes treated with insulin pump","volume":"40","author":"Dori-Dayan","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"issue":"5","key":"2025062422033822800_dgae914-B12","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.2337\/diacare.27.5.1200","article-title":"Hba1c levels are significantly lower in early and late pregnancy","volume":"27","author":"Nielsen","year":"2004","journal-title":"Diabetes Care"},{"issue":"10","key":"2025062422033822800_dgae914-B13","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2337\/diacare.15.10.1251","article-title":"Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy","volume":"15","author":"Combs","year":"1992","journal-title":"Diabetes Care"},{"issue":"3","key":"2025062422033822800_dgae914-B14","doi-asserted-by":"crossref","first-page":"100031","DOI":"10.1016\/j.ajogmf.2019.100031","article-title":"Adherence to self-glucose monitoring recommendations and perinatal outcomes in pregnancies complicated by diabetes mellitus","volume":"1","author":"Wernimont","year":"2019","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"3","key":"2025062422033822800_dgae914-B15","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/0884217505276306","article-title":"Reliability of reporting of self-monitoring of blood glucose in pregnant women","volume":"34","author":"Kendrick","year":"2005","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"Supplement_1","key":"2025062422033822800_dgae914-B16","doi-asserted-by":"crossref","first-page":"S126","DOI":"10.2337\/dc24-S007","article-title":"7. Diabetes technology: standards of care in diabetes\u20142024","volume":"47","author":"American Diabetes Association Professional Practice Committee","year":"2024","journal-title":"Diabetes Care"},{"issue":"10","key":"2025062422033822800_dgae914-B17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/dia.2021.0109","article-title":"Comparison of glycemic metrics measured simultaneously by intermittently scanned continuous glucose monitoring and real-time continuous glucose monitoring in pregnant women with type 1 diabetes","volume":"23","author":"N\u00f8rgaard","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"14","key":"2025062422033822800_dgae914-B18","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa0805017","article-title":"Continuous glucose monitoring and intensive treatment of type 1 diabetes","volume":"359","author":"Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group","year":"2008","journal-title":"N Engl J Med"},{"issue":"6","key":"2025062422033822800_dgae914-B19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M16-2855","article-title":"Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial","volume":"167","author":"Beck","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"2025062422033822800_dgae914-B20","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1089\/dia.2021.0212","article-title":"Use of real-time continuous glucose monitoring improves glycemic control and other clinical outcomes in type 2 diabetes patients treated with less intensive therapy","volume":"24","author":"Grace","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"2025062422033822800_dgae914-B21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2337\/diacare.21.4.535","article-title":"The effect of glycemic control in the pre-conception period and early pregnancy on birth weight in women with IDDM","volume":"21","author":"Gold","year":"1998","journal-title":"Diabetes Care"},{"issue":"10110","key":"2025062422033822800_dgae914-B22","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"issue":"8","key":"2025062422033822800_dgae914-B23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1089\/dia.2023.0548","article-title":"Clinical effectiveness of continuous glucose monitoring in pregnancies affected by type 1 diabetes","volume":"26","author":"Gao","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"2025062422033822800_dgae914-B24"},{"issue":"2","key":"2025062422033822800_dgae914-B25","doi-asserted-by":"crossref","first-page":"E627","DOI":"10.9778\/cmajo.20200128","article-title":"The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes in 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial","volume":"9","author":"Ahmed","year":"2021","journal-title":"CMAJ Open"},{"issue":"2","key":"2025062422033822800_dgae914-B26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1089\/dia.2018.0310","article-title":"The relationship of hemoglobin A1C to time-in-range in patients with diabetes","volume":"21","author":"Vigersky","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"2025062422033822800_dgae914-B27","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00125-019-4850-0","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies","volume":"62","author":"Kristensen","year":"2019","journal-title":"Diabetologia"},{"issue":"1","key":"2025062422033822800_dgae914-B28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12884-016-0961-5","article-title":"CONCEPTT: continuous glucose monitoring in women with type 1 diabetes in pregnancy trial: a multi-center, multi-national, randomized controlled trial\u2014study protocol","volume":"16","author":"Feig","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"issue":"8","key":"2025062422033822800_dgae914-B29","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1089\/dia.2023.0583","article-title":"Mean glucose and gestational weight gain as predictors of large-for-gestational-age infants in pregnant women with type 1 diabetes using continuous glucose monitoring","volume":"26","author":"S\u00f8holm","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"2025062422033822800_dgae914-B30","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2337\/dc22-0078","article-title":"Continuous glucose monitoring metrics and birth weight: informing management of type 1 diabetes throughout pregnancy","volume":"45","author":"Scott","year":"2022","journal-title":"Diabetes Care"},{"issue":"5","key":"2025062422033822800_dgae914-B31","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1055\/a-1904-9279","article-title":"Time in range and pregnancy outcomes in people with diabetes using continuous glucose monitoring","volume":"40","author":"Fishel Bartal","year":"2023","journal-title":"Am J Perinatol"},{"issue":"1","key":"2025062422033822800_dgae914-B32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/dc23-0636","article-title":"Association of continuous glucose monitoring metrics with pregnancy outcomes in patients with preexisting diabetes","volume":"47","author":"Sanusi","year":"2024","journal-title":"Diabetes Care"},{"issue":"4","key":"2025062422033822800_dgae914-B33","doi-asserted-by":"crossref","first-page":"467.e1","DOI":"10.1016\/j.ajog.2024.01.010","article-title":"Continuous glucose monitoring in pregnancies with type 1 diabetes: small increases in time-in-range improve maternal and perinatal outcomes","volume":"231","author":"Sobhani","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2025062422033822800_dgae914-B34","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/dia.2021.0194","article-title":"Novel continuous glucose monitoring metrics and large-for-gestational-age risk: an exploratory retrospective cohort study in pregnancies with type 1 diabetes","volume":"24","author":"Sibiak","year":"2022","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2025062422033822800_dgae914-B35","doi-asserted-by":"crossref","first-page":"122.e1","DOI":"10.1016\/j.ajog.2024.03.026","article-title":"Discrete glucose profiles identified using continuous glucose monitoring data and their association with adverse pregnancy outcomes","volume":"231","author":"Battarbee","year":"2024","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"2025062422033822800_dgae914-B36","first-page":"CD005542","article-title":"Continuous subcutaneous insulin infusion versus multiple daily injections of insulin for pregnant women with diabetes","volume":"2016","author":"Farrar","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"2025062422033822800_dgae914-B37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.17925\/EE.2022.18.1.27","article-title":"Review of automated insulin delivery systems for type 1 diabetes and associated time in range outcomes","volume":"18","author":"Nallicheri","year":"2022","journal-title":"touchREV Endocrinol"},{"issue":"7","key":"2025062422033822800_dgae914-B38","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1602494","article-title":"Closed-loop insulin delivery during pregnancy in women with type 1 diabetes","volume":"375","author":"Stewart","year":"2016","journal-title":"N Engl J Med"},{"issue":"7","key":"2025062422033822800_dgae914-B39","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2337\/dc17-2534","article-title":"Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial","volume":"41","author":"Stewart","year":"2018","journal-title":"Diabetes Care"},{"key":"2025062422033822800_dgae914-B40","author":"Lee"},{"issue":"6","key":"2025062422033822800_dgae914-B41","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-8587(24)00089-5","article-title":"Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial","volume":"12","author":"Benhalima","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2025062422033822800_dgae914-B42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/dia.2024.0012","article-title":"Randomized trial of assisted hybrid closed-loop therapy versus sensor-augmented pump therapy in pregnancy","volume":"26","author":"Polsky","year":"2024","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"2025062422033822800_dgae914-B43","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1089\/dia.2022.0479","article-title":"Rollout of closed-loop technology to pregnant women with type 1 diabetes: healthcare professionals\u2019 views about potential challenges and solutions","volume":"25","author":"Rankin","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"2025062422033822800_dgae914-B44","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2337\/dc10-1796","article-title":"Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes","volume":"34","author":"Murphy","year":"2011","journal-title":"Diabetes Care"},{"issue":"12","key":"2025062422033822800_dgae914-B45","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2337\/dc11-1430","article-title":"Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series","volume":"34","author":"Murphy","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"2025062422033822800_dgae914-B46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/dia.2022.0540","article-title":"Expert guidance on off-label use of hybrid closed-loop therapy in pregnancies complicated by diabetes","volume":"25","author":"Szmuilowicz","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"2025062422033822800_dgae914-B47","author":"Tidepool Healthcare Professionals website"},{"key":"2025062422033822800_dgae914-B48"},{"key":"2025062422033822800_dgae914-B49"},{"issue":"12","key":"2025062422033822800_dgae914-B50","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2337\/dc23-0882","article-title":"A randomized trial of closed-loop insulin delivery postpartum in type 1 diabetes","volume":"46","author":"Donovan","year":"2023","journal-title":"Diabetes Care"},{"issue":"7","key":"2025062422033822800_dgae914-B51","doi-asserted-by":"crossref","first-page":"100969","DOI":"10.1016\/j.ajogmf.2023.100969","article-title":"Continuous glucose monitor use in type 2 diabetes mellitus in pregnancy and perinatal outcomes: a systematic review and meta-analysis","volume":"5","author":"Wilkie","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"5","key":"2025062422033822800_dgae914-B52","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/AOG.0000000000005609","article-title":"Continuous glucose monitoring for management of type 2 diabetes and perinatal outcomes","volume":"144","author":"Padgett","year":"2024","journal-title":"Obstet Gynecol"},{"issue":"3","key":"2025062422033822800_dgae914-B53","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/dia.2017.0386","article-title":"Accuracy, user acceptability, and safety evaluation for the FreeStyle libre flash glucose monitoring system when used by pregnant women with diabetes","volume":"20","author":"Scott","year":"2018","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2025062422033822800_dgae914-B54","doi-asserted-by":"crossref","first-page":"e14703","DOI":"10.1111\/dme.14703","article-title":"Efficacy of continuous glucose monitoring on maternal and neonatal outcomes in gestational diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials","volume":"39","author":"Garc\u00eda-Moreno","year":"2022","journal-title":"Diabet Med"},{"issue":"12","key":"2025062422033822800_dgae914-B55","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1210\/jc.2013-4332","article-title":"Continuous glucose monitoring effects on maternal glycemic control and pregnancy outcomes in patients with gestational diabetes mellitus: a prospective cohort study","volume":"99","author":"Yu","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025062422033822800_dgae914-B56","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/dme.13649","article-title":"Continuous glucose monitoring results in lower HbA1c in Malaysian women with insulin-treated gestational diabetes: a randomized controlled trial","volume":"35","author":"Paramasivam","year":"2018","journal-title":"Diabet Med"},{"issue":"5","key":"2025062422033822800_dgae914-B57","doi-asserted-by":"crossref","first-page":"5714","DOI":"10.21037\/apm-21-439","article-title":"The effects of the instantaneous scanning glucose monitoring system on hypoglycemia, weight gain, and health behaviors in patients with gestational diabetes: a randomised trial","volume":"10","author":"Zhang","year":"2021","journal-title":"Ann Palliat Med"},{"issue":"3","key":"2025062422033822800_dgae914-B58","doi-asserted-by":"crossref","first-page":"e003989","DOI":"10.1136\/bmjdrc-2023-003989","article-title":"Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies","volume":"12","author":"Carlson","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"S 01","key":"2025062422033822800_dgae914-B59","doi-asserted-by":"crossref","first-page":"e1370","DOI":"10.1055\/s-0043-1764208","article-title":"Continuous glucose monitoring and time in range: association with adverse outcomes among people with type 2 or gestational diabetes Mellitus","volume":"41","author":"Bitar","year":"2024","journal-title":"Am J Perinatol"},{"key":"2025062422033822800_dgae914-B60","first-page":"100823","article-title":"Continuous glucose monitoring-derived glycemic metrics and adverse pregnancy outcomes among women with gestational diabetes: a prospective cohort study","volume":"39","author":"Liang","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"issue":"Supplement_1","key":"2025062422033822800_dgae914-B61","doi-asserted-by":"crossref","first-page":"65-OR","DOI":"10.2337\/db24-65-OR","article-title":"65-OR: continuous glucose monitoring metrics and suboptimal pregnancy outcomes in women with gestational diabetes\u2014secondary analysis of the DiGest trial","volume":"73","author":"Kusinski","year":"2024","journal-title":"Diabetes"},{"issue":"5","key":"2025062422033822800_dgae914-B62","doi-asserted-by":"crossref","first-page":"810","DOI":"10.2337\/dc18-2212","article-title":"Suboptimal nocturnal glucose control is associated with large for gestational age in treated gestational diabetes mellitus","volume":"42","author":"Law","year":"2019","journal-title":"Diabetes Care"},{"issue":"8","key":"2025062422033822800_dgae914-B63","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.2337\/dc23-2149","article-title":"Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus","volume":"47","author":"Durnwald","year":"2024","journal-title":"Diabetes Care"},{"issue":"5","key":"2025062422033822800_dgae914-B64","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1177\/19322968231161317","article-title":"All children deserve to be safe, mothers too: evidence and rationale supporting continuous glucose monitoring use in gestational diabetes within the medicaid population","volume":"18","author":"Levy","year":"2024","journal-title":"J Diabetes Sci Technol"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae914\/61369255\/dgae914.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/7\/e2317\/61369255\/dgae914.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/7\/e2317\/61369255\/dgae914.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T02:03:51Z","timestamp":1750817031000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/7\/e2317\/7944771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,7]]},"references-count":64,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,1,7]]},"published-print":{"date-parts":[[2025,6,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae914","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7]]},"published":{"date-parts":[[2025,1,7]]}}}